Document Detail

Azathioprine in 50 rheumatoid arthritic patients intolerant or unresponsive to gold or penicillamine.
MedLine Citation:
PMID:  4064585     Owner:  NLM     Status:  MEDLINE    
This is a retrospective review of 50 rheumatoid patients who had experienced side effects with gold and/or penicillamine and who were treated with azathioprine in routine clinical practice. The mean duration of the disease at commencement of azathioprine was 9.4 years; despite attempts to maintain the dose at 2.5 mg/kg.d because of minor side effects the average daily dose was 1.68 mg/kg.d. By one year, 11 (22%) had discontinued the drug due to side effects; 6 (12%) had not improved in any respect, 20 (40%) had a reduction in the total number of active joints with maintenance of function and in 13 (26%) the total number of active joints had been reduced by more than a half. During year 2 a further 4 discontinued therapy for adverse reactions. No further formal analysis has been performed though 31 patients were still on the drug with a mean duration of therapy for a period of 5 years. Ten of these had less than half their originally affected joints still active; this condition was usually associated with a fall in ESR and rise in haemoglobin but this was not invariable.
E A Jenkins; B M Ansell; M A Hall; S P Liyanage
Related Documents :
24320905 - Role of arginine and fluoride in the prevention of eroded enamel: an in vitro model.
9621475 - Efficacy of methotrexate in rheumatoid arthritis.
20810495 - Power doppler ultrasonography assessment of entheses in spondyloarthropathies: response...
3318725 - Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and re...
15050485 - Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta ...
17213265 - Impact of imipenem resistance on mortality in patients with acinetobacter bacteraemia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical rheumatology     Volume:  4     ISSN:  0770-3198     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  1985 Sep 
Date Detail:
Created Date:  1986-01-08     Completed Date:  1986-01-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  278-80     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis, Rheumatoid / drug therapy*
Azathioprine / therapeutic use*
Blood Sedimentation
Gold / therapeutic use*
Hemoglobins / analysis
Middle Aged
Penicillamine / therapeutic use*
Retrospective Studies
Rheumatoid Factor / analysis
Reg. No./Substance:
0/Hemoglobins; 446-86-6/Azathioprine; 52-67-5/Penicillamine; 7440-57-5/Gold; 9009-79-4/Rheumatoid Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of an intravenous saline load on erythrocyte sodium transport in normal human subjects.
Next Document:  25-Hydroxycholecalciferol in experimental osteoporosis.